Quan Dong Nguyen MD
Retinal Disease, Uveitis
Professor of Ophthalmology, Director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University Former Director and Chairman, Truhlsen Eye Institute, University of Nebraska Medical Center Former Assistant Dean for Translational Research, University of Nebraska Medical Center
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Nguyen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1994 - 1997
Perelman School of Medicine at the University of PennsylvaniaClass of 1994
Certifications & Licensure
CA State Medical License 2016 - 2026
NE State Medical License 2013 - 2018
MD State Medical License 1998 - 2013
DC State Medical License 1998 - 2002
VA State Medical License 1998 - 2002
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study Start of enrollment: 2008 Apr 01
- Sirolimus as Therapeutic Approach to Uveitis Start of enrollment: 2009 Jul 01
- Intravitreal Sirolimus as Therapeutic Approach to Uveitis Start of enrollment: 2022 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Utilization of an automated machine learning approach for the detection of granular corneal dystrophy via slit lamp photographs.Negin Yavari, S Saeed Mohammadi, Jared T Sokol, Dalia El Feky, MohammadBagher Rajabi
BMC Ophthalmology. 2025-11-22 - Correction: New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway.Sobha Sivaprasad, Chui Ming Gemmy Cheung, Martin Gliem, Charles C Wykoff, Nina Zippel
Eye. 2025-11-07 - Assessing and monitoring abnormal retinal blood circulation for early detection of pre-structural damage and enhanced diabetic retinopathy staging using non-invasive, ...Ali Basiri, Caesar Luo, Mohammad Shokoohi-Yekta, Theodore Leng, Hossein Taheri
Eye. 2025-11-01
Journal Articles
- Blue Light Versus Green Light Fundus Autofluorescence in Normal Subjects and in Patients with Retinochoroidopathy Secondary to Retinal and Uveitic DiseasesQuan Nguyen, MD, Springer Open
- Diurnal Variation of Choriocapillaris Vessel Flow Density in Normal Subjects Measured Using Optical Coherence Tomography AngiographySalman Sarwar, Quan Dong Nguyen, Aniruddha Agarwal, BioMed Central
Authored Content
- Brolucizumab: Evolution Through Preclinical and Clinical Studies, and the Implications for the Management of nAMDJanuary 2020
Press Mentions
VivaVision Strengthens Scientific Advisory Board with a World-Renowned Expert in OphthalmologyAugust 12th, 2025- LumiThera Announces Sustained Vision Improvement for 24 Months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial DataMarch 15th, 2023
- Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to Discuss LBS-008 Interim DataOctober 20th, 2022
- Join now to see all
Grant Support
- Mechanisms Of Glucose ToxicityNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Novel Assessment Of Early Changes In Diabetic RetinopathyNational Eye Institute2008–2010
- Supplemental Oxygen For Hypoxia-Related Retinal DeseasesNational Eye Institute2001–2005
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
